Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ·Healthcare·Biotechnology
$67.39
-6.22%
Mkt Cap $9.36B
Analyst Ratings
Buy
14
Hold
0
Sell
0
Price Target (37 analysts)
$104.43
Range $46.00 – $126.00
Implied Upside
+55.0%
Consensus $104.43 vs current $67.39